St. Jude Begins Expanded Renal Denervation Study

St. Jude Medical has announced enrollment of the first patient in the EnligHTN II trial, a post-market clinical study that will further evaluate the safety and efficacy of the EnligHTN™ Renal Denervation System in patients with uncontrolled hypertension. Building on results from the initial EnligHTN study of 46 patients, this expanded study will enroll 500 patients in 40 centers throughout Europe and Australia with five year follow-up.
Source: News from Angioplasty.Org - Category: Cardiology Source Type: news